Evolving role of viadisc for chronic low back and discogenic pain: a narrative review

IF 2.7 3区 医学 Q2 PHARMACOLOGY & PHARMACY Expert Opinion on Emerging Drugs Pub Date : 2024-04-11 DOI:10.1080/14728214.2024.2339912
Jack K. Tolson, Robert L. Menuet, Gianni H. Ly, Benjamin A. Chanes, Elizabeth A. Bryan, Saurabh Kataria, Julian Kim, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D. Kaye
{"title":"Evolving role of viadisc for chronic low back and discogenic pain: a narrative review","authors":"Jack K. Tolson, Robert L. Menuet, Gianni H. Ly, Benjamin A. Chanes, Elizabeth A. Bryan, Saurabh Kataria, Julian Kim, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D. Kaye","doi":"10.1080/14728214.2024.2339912","DOIUrl":null,"url":null,"abstract":"Chronic lower back pain is a leading cause of disability and healthcare spending worldwide. Discogenic pain, pain originating from the intervertebral disk, is a common etiology of chronic lower bac...","PeriodicalId":12292,"journal":{"name":"Expert Opinion on Emerging Drugs","volume":"59 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Emerging Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14728214.2024.2339912","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic lower back pain is a leading cause of disability and healthcare spending worldwide. Discogenic pain, pain originating from the intervertebral disk, is a common etiology of chronic lower bac...
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
viadisc 在治疗慢性腰痛和椎间盘源性疼痛方面不断演变的作用:叙述性综述
慢性下背痛是导致全球残疾和医疗支出的主要原因。椎间盘源性疼痛,即源自椎间盘的疼痛,是慢性下背痛的常见病因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.90
自引率
0.00%
发文量
28
审稿时长
>12 weeks
期刊介绍: Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.
期刊最新文献
Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape. Emerging therapeutic strategies in immune thrombocytopenia: an expert evaluation of the evolving treatment landscape. What can we expect from a combination of datopotamab deruxtecan, carboplatin, and pembrolizumab for brain metastases from non-small cell lung cancer? Targeting the gut microbiota as a treatment for obesity and cancer cachexia. Exploring the latest emerging drugs for the treatment of sickle cell disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1